Podcasts about drug companies

This New Movie Monday we visit the rich and face the mythical in Death of a Unicorn. We are joined briefly by Griffey's son Hunter for his thoughts on the movie, discuss what we thought of the brutal Unicorns, and if the movie needed more to say. Join us as we face down these evil rich pharmacutical family and hardcore cyptids in this new A24 Horror Comedy.  Synopsis: Father-Daughter duo Elliott and Ridley hit a unicorn with their car and bring it to the wilderness retreat of a mega-wealthy pharmaceutical CEO. Starring: Jenna Ortega, Paul Rudd, Will Poulter, Tea Leoni, Richard E. Grant Directed by Alex Scharfman Join the Misfit Parade: https://www.misfitparade.com/ Support the show on the Patreon: https://www.patreon.com/messedupmoviespod Watch our newest short film Sugar Tits Now! https://www.youtube.com/watch?v=Sz7leFqqo4g  

On this episode, Betsy Kipnis, a multi-hyphenate who loves a wide variety of authors, and I discuss some shared favorites, great Chicago bookstores, and she has some great stories. She discusses books that are multi-sensory and we get spicy about a beloved author.    Betsy's Blog - Bookisshh Barbara Kingsolver's Recovery Center    Books mentioned in this episode:    What Betsy's reading:  The Road to the Salt Sea by Samuel Kọláwọlé Fundamentally by Nussaibah Younis     Books Highlighted by Betsy: Black Butterflies by Priscilla Morris  How to Say Babylon by Safiya Sinclair The Lovely Bones by Alice Sebold  Forty Rooms by Olga Grushin The Island of Missing Trees by Elif Shafak  The Vegetarian by Han Kang  Human Acts by Han Kang  Native Son by Richard Wright  Furious Hours: Murder, Fraud, and the Last Trial of Harper Lee by Casey Cep Meditations for Mortals: Four Weeks to Embrace Your Limitations and Make Time for What Counts by Oliver Burkeman    All books available on my Bookshop.org episode page.   Other books mentioned in this episode: Chocolat by Joanne Harris  Annie Bot by Sierra Greer  Hum by Helen Phillips  The Handmaid's Tale by Margaret Atwood  Colored Television by Danzy Senna We Do Not Part by Han Kang  Flowers in the Attic by V.C. Andrews  Are You There God? It's Me, Margaret by Judy Blume  Rouge by Mona Awad  Perfume: The Story of a Murderer by Patrick Suskind  The Nightingale by Kristin Hannah  Yellowface by R.F. Kuang  Hello Beautiful by Ann Napolitano  Interior Chinatown by Charles Yu  Breasts and Eggs by Meiko Kwakami  Girl in Snow by Danya Kukafka  Hillbilly Elegy: A Memoir of a Family and Culture in Crisis by J.D. Vance  Dopesick: Dealers, Doctors, and the Drug Company that Addicted America by Beth Macy  Educated: A Memoir by Tara Westover  The Guest by Emma Cline The Girls by Emma Cline  Luster by Raven Leilani  The Bean Trees by Barabara Kingsolver  The Joy Luck Club by Amy Tan  There Are No Children Here: The Story of Two Boys Growing Up in the Other America by Alex Kotlowitz  Oedipus Rex by Sophocles  There are Rivers in the Sky by Eilf Shafak  Ducks, Newburyport by Lucy Ellmann  In Cold Blood by Truman Capote To Kill a Mockingbird by Harper Lee  Go Set a Watchman by Harper Lee  Four Thousand Weeks: Time Management for Mortals by Oliver Burkeman

Dr. Bryan Ardis, A healthcare whistleblower and the author of the bestselling book "Moving Beyond the Covid-19 Lies: Restoring Health and Hope for Humanity" joined the show to discuss why drug companies want a pause in price negotiations with the US Govt. See omnystudio.com/listener for privacy information.

​Title: With The Wind with Dr. Paul - Show 162; Pediatric Perspectives: -Reviewing Turtles All The Way Down With Zoey O'Toole Presenters: Dr. Paul Thomas, Zoey O'Toole Length: 30 minutes Links to Websites: DoctorsandScience.com Kids First Forever Donate to Children's Health Defense Sign Up for Children's Health Defense Updates Turtles All the Way Down on Amazon The Lancet Journal BMJ Journal The Truth About the Drug Companies on Amazon VAERS – Vaccine Adverse Event Reporting System Key Points: 00:00:59 - Introduction to Turtles All the Way Down and Zoey O'Toole's role as editor 00:03:00 - Discussion on vaccine trials and lack of placebo testing 00:05:01 - The placebo problem: How studies often use previous vaccines as controls 00:10:10 - "Who are the companies obligated to?" – Exploring pharmaceutical companies' priorities 00:13:11 - Uncovering flaws in vaccine safety studies 00:18:30 - Harvard Pilgrim study on adverse events, challenges with VAERS 00:23:50 - Advice to parents on vaccine decisions and trusting intuition Summary: Dr. Paul welcomes Zoey O'Toole, editor of Turtles All the Way Down, to discuss the book's insights on vaccine trials and the limitations of current safety data. They delve into how vaccines are tested, what is often hidden from public view, and explore studies showing potential flaws in the vaccine approval process. The conversation highlights the importance of informed consent and trusting one's intuition, especially regarding children's health. Conclusion: The episode encourages listeners to ask questions, trust their instincts, and thoroughly understand vaccine safety to make informed health decisions for their families. Hashtags: #PediatricPerspectives, #TurtlesAllTheWayDown, #VaccineSafety, #InformedConsent, #HealthAndWellness

SourceQuotes from article. "Trends Shaping The Psychedelic Drugs MarketKey trends include a focus on public education, regulatory adaptation, and diversification of compounds. Companies such as Pfizer, Johnson & Johnson and Mydecine Innovations Group are actively advancing in this sector to develop treatments that cater to evolving patient needs. North America currently leads the market, with Asia-Pacific expected to see the fastest growth through 2033 due to increasing policy changes and investment in mental health infrastructure." ---Celebrate, The Savior is Here!Jesus Christ is Alive!Get to know Jesus Christ, He will change your life!!!Go to GOD for discernment and wisdom.Know the Truth as the Truth will make you free! (John 8:32)___The Pledge of AllegianceNEO420 = Real News + Real Information for WE THE PEOPLEWE THE PEOPLE are at war with the deepstate criminal cabal!!!Turn off your tv, radio, and stop listening to paid professional liars spreading propaganda.***SUPPORT Independent Free Speech Reporting***Thank you for the SUPPORT & SHARING the TRUTH!!!___Podcast  link is here http://neo420.com/talks-podcast/The video channel link is here. https://odysee.com/@NEO420TALKS:4The Viral Delusionhttp://www.theviraldelusion.com/HAARPDARPA BlackjackAshli Babbit false flag Jan 6 video evidence___NEVER FORGET 9 11!!!Rumsfeld admitted $2.3 Trillion missing from Pentagon Sept 10 2001.  https://odysee.com/@NEO420TALKS:4/rumsfeld-2.1Trillionunaccountedforb-ccriminalsstoleit:7Planes did NOT bring down the two towers.AE911Truth.orgGeorge Bush Sr was CIA director before being Vice President then President.Towers that fell:-Building 1-Building 2-Building 7 (seldom reported even though BBC reporter reported building down before it happened) https://www.youtube.com/watch?v=J0VFMqi--Copyright Disclaimer Under Section 107 of the Copyright Act 1976, allowance is made for "fair use" for purposes such as criticism, comment, news reporting, teaching, scholarship, and research. Fair use is a use permitted by copyright statute that might otherwise be infringing. Non-profit, educational or personal use tips the balance in favor of fair use.Support the show

Episode 96 - What a Harvard MD Wants You to Know About the Drug Companies, medical intuitive healer Catherine Carrigan interviews author Dr. John Abramson. Disclaimer: Please note that all information and content on the UK Health Radio Network, all its radio broadcasts and podcasts are provided by the authors, producers, presenters and companies themselves and is only intended as additional information to your general knowledge. As a service to our listeners/readers our programs/content are for general information and entertainment only.  The UK Health Radio Network does not recommend, endorse, or object to the views, products or topics expressed or discussed by show hosts or their guests, authors and interviewees.  We suggest you always consult with your own professional – personal, medical, financial or legal advisor. So please do not delay or disregard any professional – personal, medical, financial or legal advice received due to something you have heard or read on the UK Health Radio Network.

Episode 21: Bristol Myers Squibb Co v. Secretary United States Department of HHS Bristol Myers Squibb Co. v. Secretary United States Department of HHS, consolidated under AstraZeneca Pharmaceuticals LP et al v. Secretary United States Department of HHS, argued before Circuit Judges Thomas M. Hardiman, Peter J. Phipps, and Arianna J. Freeman in the U.S. Court of Appeals for the Third Circuit on October 30, 2024. First Amendment question argued by Kevin F. King (on behalf of Bristol Myers Squibb Co., et al.) and Catherine M. Padhi (on behalf of the government). Note: the court separated the various constitutional issues from the consolidated cases into distinct portions of the oral arguments.  What follows, both in terms of content and audio, relates specifically to the First Amendment question, which is the second of the three issues listed below. The other portions of the oral argument are not included in this podcast.Statement of the Issues, from the Opening Brief for Appellant: Whether the Program effects takings that require just compensation under the Fifth Amendment. Whether the Program compels speech in violation of the First Amendment. Whether a manufacturer's submission to the Program's demands is “voluntary” and immune from constitutional scrutiny. Background on the Drug Price Negotiation Program, from the Institute's case page: The program requires drug manufacturers to adopt these messages [that they “agreed” to a new “maximum fair price,”]—even when those companies disagree. Failure to do so would subject the companies to staggering excise tax penalties on every domestic sale, as well as forced withdrawal of all products from Medicare and Medicaid. Resources: Court Listener docket page Opening Brief for Appellant Brief for Appellees Institute for Free Speech amicus brief Institute for Free Speech case page (includes additional information) The Institute for Free Speech promotes and defends the political speech rights to freely speak, assemble, publish, and petition the government guaranteed by the First Amendment. If you're enjoying the Free Speech Arguments podcast, please subscribe and leave a review on your preferred podcast platform. To support the Institute's mission or inquire about legal assistance, please visit our website: www.ifs.org

On this week's AJ Bell Money & Markets podcast, Danni Hewson and Charlene Young assess the market reaction to a large fall in UK inflation which has raised expectations that the Bank of England might cut rates twice before the end of the year.   They're joined by Tom Selby, AJ Bell's director of public policy, to discuss ongoing Budget speculation which has unsettled many pension savers and prompted AJ Bell to call on the Treasury to commit to a pension tax lock.   They also discuss the impact of Budget speculation on markets with housebuilders like Barratt up and gambling companies like Entain down.   Dan Coatsworth talks to Ailsa Craig and Marek Poszepczynski from the International Biotechnology Trust about what we might see next for the weight-loss drug boom. Dan also chat to Nick Purves from Temple Bar Investment Trust about finding opportunities when parts of the market look cheap.   You can also hear why automakers Stellantis and BMW have warned policy makers they need to think again about the pace of the transition to electric vehicles if they're going to protect manufacturing jobs and why Boeing is looking to raise funds to help it keep its head above water.

Ozempic and Wegovy are some of the most popular drugs in the country, driven by their remarkable success in treating diabetes and obesity. But the drugs are extremely expensive, and the drugmaker's CEO appeared on Capitol Hill Tuesday to face questions about why those prices are so high. William Brangham reports. PBS News is supported by - https://www.pbs.org/newshour/about/funders

Ozempic and Wegovy are some of the most popular drugs in the country, driven by their remarkable success in treating diabetes and obesity. But the drugs are extremely expensive, and the drugmaker's CEO appeared on Capitol Hill Tuesday to face questions about why those prices are so high. William Brangham reports. PBS News is supported by - https://www.pbs.org/newshour/about/funders

1) Fed Decision day and National Cheeseburger day 2) Seasonality says sell the rate cut 3) CANSLIM strategy - what is it and how to import it in Trendspider. 4) $APP - finding stocks - this is up 34% since it was in the newsletter 5) $SMCI, $TSLA, $MSFT 6) GLP1 drug companies ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠SEEKING ALPHA PREMIUM⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  - save up to 20% plus a FREE 7 day trial ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Sign up for ALPHA PICKS here - SAVE $50. ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠SIGN UP FOR TRENDSPIDER AND GET ALL OF THESE⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ 1) My 4 hour algorithm 2) 65 Min algorithm to day trade with 3) Custom watch lists  4) Custom Scanners to find entries  TRENDSPIDER SALE - best offer available (limited time)  Sign up at the top link ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://linktr.ee/dailystockpick ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ (use code DSP25 if prompted) Email me at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠dailystockpick3@gmail.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  I'll send you all the algorithms, watchlists and scanners that you see me use each and every day.  Social Links and more - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://linktr.ee/dailystockpick⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  FREE NEWSLETTER WITH CHARTS - subscribe at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠dailystockpick.substack.com ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠SPONSORED BY VISIBLE - Check out this page - $20 off your first month - only $5 for the first month ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Sign up for Webull and get free stocks like I did ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Get AT&T Fiber at your home - I have 1GB service ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.att.com/referral/code/?ref=TVY-3964⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ 

What will we pay for the next groundbreaking drug? In episode 4 of our 5-episode series, “Insight Unpacked: American Healthcare and Its Web of Misaligned Incentives,” we explore the trade-off at the heart of pharmaceutical innovation. On this episode, we hear from Kellogg faculty members Amanda Starc and Craig Garthwaite, as well as Boston University School of Law's Kevin Outterson.  Visit the episode page for supplementary materials. 

President Joe Biden has called on major drug companies to cut the price of weight loss medication Hurricane Beryl, a category 5 storm is heading towards Jamaica. We hear more from disaster modeller Enki Research And Jayson Tatum will sign a five-year deal, worth $314 million dollars with the Boston Celtics, making it the largest contract in NBA history.

The world of 340B has seen significant developments on the state and national levels in recent months. A second federal appeals court decision on 340B contract pharmacies came down in recent weeks, a new bill in Congress threatens to impose significant restrictions on hospital participation in 340B program, and more states move to protect covered entities from drugmaker restrictions. To understand these new developments, 340B Health President and CEO Maureen Testoni joins us to explain more. A second federal appeals court rules for drug companies In May, the D.C. Circuit Court of Appeals ruled that the 340B statute does not categorically prohibit drug manufacturers from imposing their own conditions on 340B. However, the court did note that manufacturers cannot impose a condition that effectively prevents a covered entity from purchasing a particular drug at the 340B price. This raises the importance of entities demonstrating situations in which they are cut off from all 340B access to a drug. Another appeals court based in Chicago has yet to issue a decision in its 340B contract pharmacy case. More states ban 340B restrictions as the industry increases state lobbying efforts  So far this year, Kansas, Maryland, Minnesota, Mississippi, and West Virginia have joined Arkansas and Louisiana in enacting laws to prohibit contract pharmacy restrictions on covered entities. But the pharmaceutical industry has become much more active in opposing ongoing legislative efforts in other states. A “dark money” group also has been running ads opposing these state bills by accusing covered entities of laundering taxpayer money to subsidize care for undocumented immigrants. New pharma-backed bill in Congress would slash 340B hospital eligibility U.S. House lawmakers recently introduced a bill known as the 340B ACCESS Act. The legislation is backed by the Pharmaceutical Research & Manufacturers of America (PhRMA) and the National Association of Community Health Centers (NACHC). It would impose significant restrictions on 340B hospital eligibility and access to savings, including by restricting 340B usage for insured patients and tying participation in the 340B program directly to levels of charity care. Resources: 1.      Statement on New Federal Legislation To Restrict 340B Hospital Eligibility2.      Statement on D.C. Circuit Appeals Court Decision on Drug Companies' 340B Restrictions3.      Report: 340B Hospitals Prescribe Medicare Part D Drugs to Greater Shares of Historically Underserved Patients4.      House Energy and Commerce Oversight and Investigations Subcommittee Hearing on 340B June 4

Welcome to Omni Talk's Retail Daily Minute, sponsored by Ownit AI and Mirakl. Ownit AI helps brands and retailers win Google search by answering their shopper's questions online. Learn more at ownit.co. Mirakl is the global leader in platform business innovation for eCommerce. Companies like Macy's, Nordstrom, and Kroger use Mirakl to build disruptive growth and profitability through marketplace, dropship, and retail media. For more, visit mirakl.comHere are today's top headlines:Nordstrom is nearing completion of its transition from its fulfillment center in San Bernardino, California, to its West Coast omnichannel center in Riverside, California. Harps Food Stores is embracing in-store retail media by partnering with Grocery TV to introduce digital displays to 145 of its locations. Ahold Delhaize USA partners with Mark Cuban's Cost Plus Drug Company to offer added convenience to customers seeking affordable healthcare solutions. Stay informed with Omni Talk's Retail Daily Minute, your source for the latest and most important retail insights. Be careful out there!

In the United States, our healthcare system is based on treatment, not prevention. And a large reason why is because the pharmaceutical companies have created incentives that profit off sickness, disease, and comorbidities. But what if our healthcare industry could promote true health? Today you're going to learn about the steps that are necessary for real change in the US healthcare system. Our guest today is Calley Means. Calley is a former consultant for food and pharmaceutical companies, the co-founder of TrueMed, and the co-author of the #1 bestselling book, Good Energy. Calley is passionate about changing our healthcare system, and today he's sharing his incredible viewpoints on what we can do as a country to incite real change.  In this episode, you're going to learn about how the American healthcare system works, including how government programs are hurting people (especially children!), how doctors are trained to focus on short-term solutions, and the major problems with the pharmaceutical industry. Plus, Calley is getting specific and sharing real world policies we can implement to transform the health of our country. This is a powerful conversation and Calley's passion is contagious. Enjoy! In this episode you'll discover: What percentage of Americans have optimal cardiometabolic health. Why a siloed healthcare system is ineffective. The sad truth about the health of children and teens in the US. How all chronic diseases are connected to metabolic health. The most profitable innovation in American capitalism. Why the pandemic was a missed opportunity for better metabolic health. The critical role of empowerment in healthcare. How the US measures up against other countries in terms of health outcomes.  What role economic incentives play in our healthcare system.  The convoluted relationship between pharmaceutical companies and food research. Why chronic diseases are a powerful profit-maximizing engine.  The sad truth about diabetes in children and young adults. What percentage of tv news spending comes from the pharmaceutical industry. The major problems with the SNAP program, and how we can repair it.  What the USDA should do with sugar guidelines.  Why focusing on specific issues can affect widespread change.  How to use pretax dollars on real healthcare and root-cause solutions. The link between insulin resistance and polycystic ovarian syndrome. Why optimism is a key ingredient to changing our health.  Items mentioned in this episode include:  Ketone.com/model - Save 30% on your first subscription order of Ketone-IQ! Organifi.com/Model - Use the coupon code MODEL for 20% off + free shipping! Good Energy by Dr. Casey Means & Calley Means - Order your copy today!  TrueMed - Use pretax dollars on healthy interventions  Connect with Calley Means Website / X / Instagram  Join TMHS Facebook community - Model Nation  Be sure you are subscribed to this podcast to automatically receive your episodes:  Apple Podcasts Spotify Soundcloud Pandora YouTube  This episode of The Model Health Show is brought to you by Ketone-IQ and Organifi.  Ketone-IQ is my favorite high-performance energy in a bottle. Save 30% on your first subscription at ketone.com/model. Organifi makes nutrition easy and delicious for everyone. Take 20% off your order with the code MODEL at organifi.com/model. 

ACT MP Todd Stephenson is selling his shares in three drug companies - after Labour accused him in Parliament of being a "pharmaceutical industry plant". Deputy political editor Craig McCulloch reports.

A PHARMACEUTICAL COMPANY IN INDIA RECENTLY FAILED 10 REQUIREMENTS FOR “GOOD MANUFACTURING PRACTICES” FOLLOWING INSPECTION OF THE FACILITIES BY THE FDA. SO WHAT DOES THAT MEAN FOR THE CONTINUING DRUG SHORTAGES? WE SPEAK WITH KENNETH RAPOZA, INDUSTRY ANALYST FROM THE “COALITION FOR A PROSPEROUS AMERICA” AND FORMER STAFF FOREIGN CORRESPONDENT FOR THE WALL STREET JOURNAL.

The Federal Trade Commission's (FTC) oversight role in the pharmaceutical market is critical to the health of patients and the health care system. Aaron Kesselheim, MD, JD, MPH, and JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, discuss the FTC's policies and legal actions related to alleged misconduct, consolidation, and anticompetitive behavior in the pharmaceutical market. Related Content: Federal Trade Commission Actions on Prescription Drugs, 2000-2022

Wednesday April 17, 2024 David Egilman, Doctor Who Took On Drug Companies, Dies at 71

Dr. Peter McCullough is a cardiologist and author. He has broadly published on a range of topics in medicine with more than 1,000 publications and over 685 citations in the National Library of Medicine.  We discuss the Covid-19 pandemic, treating long-covid and vaccine injuries, heart health, Avian bird flu and more. PLEASE CHECK WITH YOUR DOCTOR BEFORE MAKING ANY CHANGES TO YOUR HEALTH, DIET, MEDICATIONS, SUPPLEMENTS ETC. 00:00 - Intro 00:13 - Avian Bird Flu 01:35 - Measles 03:20 - Covid Vaccines Slight Risk 05:40 - Turbo Cancers 07:30 - Covid Viral Mutations 08:36 - Long Covid Symptoms 09:40 - McCullough Protocol 13:46 - Silent Hypoxemia 14:20 - Reactivation of Epstein-Barr & Lyme Disease 14:55- Polymyalgia Rheumatica & Covid Vaccines 16:00 - Doctors Being Unbiased 16:38 - Blood Clots & Embalmers 17:45 - Testing for Spike Protein 18:45 - Intermittent Fasting &  Diet 24:10 - Magnesium & Vitamin D Supplements 25:00 - Ozempic, Ivermectin & Drugs 28:15 - Drug Protocol for Treating Covid30:05 - Politicians & Vaccine Response 35:45 - Natural Health & Pandemic Preparation  38:15 - FDA & Pharmaceutical Companies 39:40 - Vaccine Safety40:55 - Drug Companies, FDA Corruption & False Claims 44:20 - Covid Vaccines & Pregnant Women 45:40 - Testing for Spike Protein 47:25 - Patients with Covid Vaccine Injuries 48:00 - General Heart Health 51:30 - Follow Dr. McCullough 53:00 - Outro Dr. Peter McCullough website:https://www.petermcculloughmd.com/Chuck Shute link tree:https://linktr.ee/chuck_shuteSupport the showThanks for Listening & Shute for the Moon!

The Matter With Things: Our Brains, Our Delusions, and the Unmaking of the World (Volume 2) by: Iain McGilchrist The World Behind the World: Consciousness, Free Will, and the Limits of Science by: Erik Hoel Dopesick: Dealers, Doctors, and the Drug Company that Addicted America by: Beth Macy American Prometheus: The Triumph and Tragedy of J. Robert Oppenheimer by: Kai Bird and Martin J. Sherwin  Younger Next Year, 2nd Edition: Live Strong, Fit, Sexy, and Smart - Until You're 80 and Beyond by: Chris Crowley and Henry S. Lodge M.D. Daily Rituals: How Artists Work by: Mason Currey Meditations on First Philosophy by: Rene Descartes Lives of the Noble Greeks and Romans by: Plutarch Neuromancer by: William Gibson Aftermath: Expeditionary Force, Book 16 by: Craig Alanson

Employment While the headline numbers for the jobs report showed results that beat expectations, when you look closely at the report it shows a softening labor market which is exactly what the Fed wants to see. Nonfarm payrolls in the month of November showed a gain of 199,000 which topped the estimate of 190,000 and the unemployment rate fell to 3.7% which was better than the forecast for 3.9%. The growth of 199,000 is below the average monthly gain of 240,000 and it is also important to point out that some of the gain in November was attributed to the end of the UAW and actors strikes. In fact, while employment in manufacturing increased 28,000 in November there was a 30,000 person increase in motor vehicles and parts as workers returned from strike. The employment in information also had a gain of 10,000 in the month, but motion picture and sound recording industries added 17,000 jobs as the resolution of labor disputes came to an end in the industry. The strikes have created volatility in the numbers over the last few months and that can also be seen in the revision to September where total nonfarm payroll employment was revised lower by 35,000. With these major strikes now behind us, we should be able to see a better reading in these job numbers moving forward. Another major area the Fed likely has their eye on is the change in average hourly earnings, which points to wage inflation. In the month of November average hourly earnings increased by 4.0%, which was the lowest reading since May 2021. Overall, this report points to the concept that a soft landing is still a real possibility. I believe the labor market will continue to soften, which should be good news for inflation and our economy.   JOLTs Report While it may not look like good news when reading the headline number, the JOLTs report showed exactly what the Fed is looking for. Job openings of 8.73 million in the month of October were below the estimate of 9.4 million and showed a decline of 617,000 or 6.6% compared to the previous month. This also marked the lowest number since March 2021. While this all sounds troubling, it shows the labor market is softening which is what the Fed has wanted to see. It also shows that the labor market is still doing alright considering there are still 1.3 job openings to every available worker. Pre-pandemic this ratio stood at 1.2.   Drug Companies The Biden administration has opened the door to seize the patents of certain costly medications from drugmakers. The administration has unveiled framework that outlines the factors federal agencies should consider in deciding whether to use march-in rights, which take patents for drugs and shares them with other pharmaceutical companies if the public cannot reasonably access the medications. Officials can now factor in the price of a medication in deciding to break a patent. While this may sound like a nice practice, I do worry about the long-term ramifications. While drug companies often do have nice margins on drugs that succeed, people generally do not discuss the billions of dollars that is spent on research and development for drugs that do not succeed. If drug companies cannot offset those costs with high margins on successful drugs, the industry could have major problems. Also, what would the incentive be to spend billions of dollars on research and development for a new drug, when you could just potentially wait for another company to come up with the solution and then use their patent that has been taken from them by the government? This could ultimately stifle innovation in the industry.   Magnificent Seven Remember a few years ago the FANG stocks? They have now been replaced by what is known as the Magnificent Seven which are Apple, Microsoft, Alphabet, Amazon, Nvidia, Tesla, and Meta. People still believe index investing is a great way to invest and diversify your portfolio, but when you look at the S&P 500 you should realize that the Magnificent Seven have carried the index to a year-to-date return of around 20%. If you look at that equal weight index it is actually only up around 6% this year. Also, in the index 44% of stocks are showing negative results. You may think you had diversification with the S&P 500 but currently the seven stocks account for close to 30% of the index. These companies stock prices have continued to perform, but history has proven time and time again that any equity trading at such high valuations eventually comes back to reality. When that happens investors in these seven stocks, and also the index will have disappointing returns. Unfortunately, I cannot tell you when it will happen, only that history has proven itself to be right 100% of the time.   Financial Planning: Reviewing Income at the End of the Year As we get closer to the end of the year, it is getting more important to review income levels and make any necessary adjustments before December 31st. When analyzing income, it is helpful to identify the expected level of adjusted gross income (AGI), the number of itemized deductions (if any), the amount of total taxable income, and the amount of taxable income subject to ordinary income rates. Adjusted gross income is the sum of all reportable income which could be wages, capital gains, interest, IRA distributions, and Social Security to name a few. After tallying AGI, next is the itemized deductions which include mortgage interest, state income and property taxes, charitable donations, and medical expenses. Taxpayers can claim the larger of the itemized deductions or the standard deduction which is $27,700 for a married couple in 2023. These deductions act as an expense which reduces the adjusted gross income and results in taxable income (AGI – deduction = taxable income). From there the long-term capital gain and qualified dividend portion of income can be separated from the other ordinary taxable income as capital gains and dividends are taxed at a lower rate (taxable income = ordinary + capital gains and dividends). From this point a taxpayer can determine what tax bracket they will be in, the tax rate of their capital gains and dividends, and whether their income will trigger any additional net investment income tax or Medicare premiums. Finally, action can be taken such as Roth conversions, realizing gains or losses, charitable donations, or retirement contributions to push income in a more efficient direction.

Today on Finding Freedom it's a solo show! Here's the topics: Adulteration of the Covid vaccine - Steve Kirsch Rumble stream Donald Trump Jr has had enough war Digging into some interesting income data and Distrust in Media is skyrocketing 6 Terrifying Steps for Gaza to spiral into WWIII Subscribe to John's Finding Freedom Show solo feed. Listen and Subscribe on Apple Podcasts and Spotify. Get access to all of our bonus audio content, livestreams, behind-the-scenes segments and more for as little as $5 per month by joining the Lions of Liberty Pride on Patreon OR support us on Locals! AND our new perk for $10 and up patrons 15% off coffee at Run Your Mouth Coffee! Check out our merchandise at the Lions of Liberty Store for all of our awesome t-shirts, mugs and hats! Learn more about your ad choices. Visit megaphone.fm/adchoices

Today on Finding Freedom it's a solo show! Here's the topics: Adulteration of the Covid vaccine - Steve Kirsch Rumble stream Donald Trump Jr has had enough war Digging into some interesting income data and Distrust in Media is skyrocketing 6 Terrifying Steps for Gaza to spiral into WWIII Subscribe to John's Finding Freedom Show solo feed. Listen and Subscribe on Apple Podcasts and Spotify. Get access to all of our bonus audio content, livestreams, behind-the-scenes segments and more for as little as $5 per month by joining the Lions of Liberty Pride on Patreon OR support us on Locals! AND our new perk for $10 and up patrons 15% off coffee at Run Your Mouth Coffee! Check out our merchandise at the Lions of Liberty Store for all of our awesome t-shirts, mugs and hats! Learn more about your ad choices. Visit megaphone.fm/adchoices

Ray Moynihan is an accomplished health journalist and author who has won several awards for his work. He is also an academic at Bond University and a documentary filmmaker. Moynihan's research and writing focus on the healthcare industry, with an emphasis on how diseases are created, branded, and marketed to unsuspecting people. He is known for his use of sharp humor, which can be seen in his mock documentary about a fictional illness called 'Motivational Deficiency Disorder.' He is also a founding member of the international conference Preventing Overdiagnosis and hosts the podcast The Recommended Dose. Today, we will be discussing something that the speaker refers to as "an assault on being human" - the labeling of everyday life struggles as disorders and how patient advocacy groups, doctors, medical journalists, and respected academics are often manipulated by a powerful, corporatized healthcare system. *** Thank you for being with us to listen to the podcast and read our articles this year. MIA is funded entirely by reader donations. If you value MIA, please help us continue to survive and grow. Mad in America podcasts and reports are made possible, in part, by a grant from the Thomas Jobe Fund. To find the Mad in America podcast on your preferred podcast player, click here

It's National Substance Abuse Prevention Month, and Stephanie Zidek, MSN, RN, AGCNS-BC, NEA-BC, NPD-BC, and Naomi Fox, MSN, RN, NPD-BC, CCRN, are joined on this episode of NPD Forecast by an expert on substance use disorders (SUDs)—Whitney Fear, RN, MSN, PMHNP-BC, PMH-C, a psychiatric nurse practitioner in Fargo, North Dakota. They discuss the crucial aspects of caring for people with SUDs and supporting nurses along the way, diving into the following topics: Suboxone's role as a life-saving medication Challenges NPD practitioners and nurses face when providing care for substance use disorder patients, including misperceptions and biases The evolution of high-risk drugs Understanding the connections between substance use, trauma, and mental health The importance of safe injection sites in harm reduction How NPD practitioners and nurses can provide more effective care by building relationships outside of health care silos During the podcast, Stephanie mentions the book Dopesick: Dealers, Doctors, and the Drug Company that Addicted America. Thanks to Elsevier for sponsoring this podcast. This episode includes a sponsored message. The opinions and viewpoints expressed in this sponsored message are the sponsor's own and do not reflect the viewpoint of the Association for Nursing Professional Development (ANPD).

Prepare yourself for a heavy dose of sarcasm on this episode of Vitality Radio as Jared takes a deep dive on the latest weight loss drug, Semaglutide - also known as Ozempic, Wegovy, and Rybelsus. You'll learn the history of this drug and just a few of its many side effects as well as the fate of many other weight loss drugs of the past. You'll also hear some tried and true alternatives for losing weight and reversing the damage that the standard American diet and environmental toxins have caused to our health, and our children's health.Products:Natural Factors WellBetX BerberineAdditional Information:Episode #227: VR Vintage: There is an Herbal Supplement that Works for Diabetes, Blood Pressure and Cholesterol Better than Drugs! Berberine is that Powerful!Visit the podcast website here: VitalityRadio.comYou can follow @vitalityradio and @vitalitynutritionbountiful on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Please also join us on the Dearly Discarded Podcast with Jared St. Clair.Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.

Big Pharma's Takeover Of Medical Knowledge Join Dr. John Abramson, M.D., as he uncovers the alarming influence of Big Pharma in shaping our medical knowledge. From clinical trials to education, he exposes the industry's grip on every aspect of our healthcare system. Don't miss out on this enlightening discussion that shakes the very foundation of medicine as we know it. Disclaimer:Medical and Health information changes constantly. Therefore, the information provided in this podcast should not be considered current, complete, or exhaustive. Reliance on any information provided in this podcast is solely at your own risk. The Real Truth About Health does not recommend or endorse any specific tests, products, procedures, or opinions referenced in the following podcasts, nor does it exercise any authority or editorial control over that material. The Real Truth About Health provides a forum for discussion of public health issues. The views and opinions of our panelists do not necessarily reflect those of The Real Truth About Health and are provided by those panelists in their individual capacities. The Real Truth About Health has not reviewed or evaluated those statements or claims. 

For decades, drugmakers have argued that patents are critical to bringing new drugs to the market. But in 2004, when a promising H.I.V. treatment emerged, Gilead Sciences decided to slow-walk its release to maximize profit on the company's existing patents.Rebecca Robbins, who covers the pharmaceutical industry for The Times, discusses one man's case and how patents can create perverse incentives to delay new and better drugs.Guest: Rebecca Robbins, a business reporter covering the pharmaceutical industry for The New York Times.Background reading: Gilead delayed a new version of a drug, allowing it to extend the patent life of a blockbuster line of medications, internal documents showed.In August, an expert panel recommended the new daily pill Descovy for H.I.V. prevention.For more information on today's episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.

Today is Thursday, August 31, and we're looking at Pfizer vs. Novavax.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

https://youtu.be/mfQfbbAOSxETry VectorVest for only $0.99  ➥➥➥ https://www.vectorvest.com/YTVectorVest Merch Store  ➥➥➥ https://vectorvest.com/MerchandiseBig news today is that big pharma companies may have to come to the table to hash out discounts on some of their drugs. Is this being done to hurt the drug companies or to help our people? The drug companies will complain that will hurt their bottom line and the people on Medicare are looking for some relief on the price of their drugs. The big question, as investors, is should we still invest in the drug companies? Will these companies still be able to make money? Well, join us to take a deeper look into the situation, get some insights, and help you make the right decisions for YOU as you look to buy or not buy these stocks!Will the Drug Industry Survive? | VectorVestUse this link for a FREE Stock Analysis Report ➥➥➥ vectorvest.com/YTFSASUBSCRIBE To The VectorVest Channel ➥➥➥ https://www.youtube.com/user/VectorVestMB/?sub_confirmation=1

https://youtu.be/chU7jBdTu3sTry VectorVest for only $0.99  ➥➥➥ https://www.vectorvest.com/YTVectorVest Merch Store  ➥➥➥ https://vectorvest.com/MerchandiseLearn about the latest trends and developments in the pharmaceutical industry with our video, "Pharma Powerhouses: Unveiling the Hot Stocks Shaking Up the Drug Industry!" Get exclusive insights into the world of drug stocks and discover which companies are making waves in this dynamic sector. In this video, we delve into the key players and their recent performances, analyzing their financial results, product pipelines, and strategic moves. Whether you're an investor seeking potential opportunities or simply interested in the pharmaceutical landscape, this video provides valuable information on the stocks currently on the rise. Stay ahead of the curve with our expert analysis on drug stocks that are constantly evolving. Drug Companies that have the potential to DOUBLE! | VectorVest

Episode SummaryOur last episode explored addiction from the perspective of loved ones. In this episode, we are looking at the opioid crisis from the point of view of a retired FBI agent, Aaron Weeter, who spent 25 years specializing in drug-related crimes. From his frontline perspective, we learn how the opioid epidemic of the 90s spread to become the fentanyl epidemic we have today. For the visually-minded who prefer to listen and read or for those who need closed captioning, watch the transcript video here: https://youtu.be/oXq6XJ_z-HIAbout Aaron WeeterBeginning in 1998, Aaron served for over 23 years as a Special Agent in the Federal Bureau of Investigation's Washington, D.C. Field Office.  He served for twenty years as a case agent and three years as a supervisor investigating matters primarily involving white-collar/financial crimes in the areas of healthcare fraud and prescription drug diversion and distribution.  During this time, Aaron also worked on a variety of national/office-wide cases including the 9-11, D.C. Sniper and January 6th investigations among others.  Aaron is a licensed Certified Public Accountant (CPA) and a Certified Fraud Examiner.  He retired from the FBI in late 2021 and recently started a fraud consulting business.  Much of Aaron's FBI investigative work focused on the illegal distribution of pharmaceutical narcotics and other controlled substances by physicians, pharmacists and street-level dealers.  He opened his first "pill case" in early 1999 in the early stages of what would become the pill epidemic and through dozens of cases thereafter, had a window into the evolution of the pill epidemic and its influence on the current fentanyl epidemic gripping the U.S.  More to Watch and ReadChasing the Dragon: The Life of an Opiate Addict - a documentary made by the FBI & DEADr. Feelgood: Dealer or Healer? - a documentary about Dr. William Hurwitz, a Virginia physician who served nearly five years in prison for drug traffickingAnonymous Sister - a documentary where director Jamie Boyle explores her family's collision with the opioid epidemicAll the Beauty and the Bloodshed - a documentary about artist and activist Nan Goldin and her personal fight to hold the Sackler family accountable for the opioid overdose crisisDemon Copperhead by Barbara Kingsolver - a novel that shows the devastating impact of the opioid epidemic on a young boy in AppalachiaDopesick: Dealers, Doctors, and the Drug Company that Addicted America by Beth Macy - the definitive account of America's opioid epidemicRaising Lazarus: Hope, Justice, and the Future of America's Overdose Crisis by Beth Macy - a sequel to DopesickDopesick - Hulu limited series remake of Beth Macy's book Empire of Pain: The Secret History of the Sackler Dynasty by Patrick Radden Keefe - a book that describes the Sackler family and their role in the opioid epidemicThe Family That Built an Empire of Pain - article by Patrick Radden Keefe that led to the bookWhat Can Be Done?Words Matter - Terms to Use and Avoid When Talking About Addictionhttps://www.cdc.gov/opioids/basics/fentanyl.html: https://www.cdc.gov/drugoverdose/prevention/index.htmlFentanyl Test StripsFind Narcan Near YouIf you or someone you know is struggling with substance use disorder, SAMHSA's (Substance Abuse and Mental Health Services Administration) National Helpline, 1-800-662-HELP (4357), (also known as the Treatment Referral Routing Service) or TTY: 1-800-487-4889 is a confidential, free, 24-hour-a-day, 365-day-a-year, information service, in English and Spanish, for individuals and family members facing mental and/or substance use disorders. This service provides referrals to local treatment facilities, support groups, and community-based organizations. Callers can also order free publications and other information. You can also visit https://www.samhsa.gov. How opioid addiction occurs - Mayo ClinicList of Treatment Facilities and Support GroupsDrug Takeback ProgramsSafe Drug DisposalRelated EpisodesAddiction to Sobriety: A Mother's JourneyAnonymous SisterFind and Follow Carole and Wisdom Shared:https://www.caroleblueweiss.com/Subscribe to my YouTube channel: https://www.youtube.com/@WisdomSharedCaroleBlueweissFollow me and send me a message on Facebook: https://www.facebook.com/caroleblueweissFollow me and send me a message on LinkedIn: https://www.linkedin.com/in/caroleblueweiss/Follow me on Instagram: https://www.instagram.com/carole_blueweiss/The Wisdom Shared TeamAudio Engineering by Steve Heatherington of Good Podcasting WorksSocial Media and Marketing Coordinator: Kayla Nelson

**THIS EPISODE CONTAINS FULL SPOILERS** ON THE SEASON 9 FINALE OF "FILM IS LIT"... immunologist and research scientist Dr. Pete Sieling (who just so happens to be Laura's Dad) finally returns to the pod to discuss Beth Macy's harrowing non-fiction book "Dopesick: Dealers, Doctors, and the Drug Company that Addicted America." The book, which details the opioid epidemic's impact in America, was adapted into a thrilling miniseries titled "Dopesick," released on Hulu. The series features a sprawling cast, which includes everyone's favorite Batman AND everyone's favorite Mr. Mom, Michael Keaton! What's even cooler is that the series was created by actor-turned-showrunner Danny Strong, who used to be on "Gilmore Girls," Laura's favorite show. Pretty neat, huh? #Dopesick #BethMacy #DannyStrong #MichaelKeaton #MichaelStuhlbarg #WillPoulter #KaitlynDever #JohnHoogenakker #PeterSarsgaard #RosarioDawson #PhillipaSoo #JakeMcDorman #DopesickHulu #Miniseries #LimitedSeries #FilmisLit #FilmisLitPodcast #FilmiLitPod #podcast #booktoscreen #movieadaptation #moviereviewpodcast #bookreviewpodcast #bookworm #cinephile #LauraSielingGaylord #DannyGaylord #RichardSackler

Predatory companies like Merck and Eli Lilly continue to pilfer Americans. Why do we allow them to exist even as they are immoral, inhumane, and parasitic? --- Send in a voice message: https://podcasters.spotify.com/pod/show/politicsdoneright/message Support this podcast: https://podcasters.spotify.com/pod/show/politicsdoneright/support

Republicans are destroying Democracy in Texas. Drug Companies / Pharmaceuticals should not exist. Teachers are jumping ship as MAGA School boards harass them. --- Send in a voice message: https://podcasters.spotify.com/pod/show/politicsdoneright/message Support this podcast: https://podcasters.spotify.com/pod/show/politicsdoneright/support

Drug Companies are nothing but parasites to Americans. We discuss why. The Republican Party is on a mission to kill Social Security, and they have it in writing. --- Send in a voice message: https://podcasters.spotify.com/pod/show/politicsdoneright/message Support this podcast: https://podcasters.spotify.com/pod/show/politicsdoneright/support

If the drug company Mallinkrodt files for a second bankruptcy, it could jeopardize opioid settlement payments to individuals as well as state and local governments. Minnesota is part of that deal reached in 2020. The news comes just days after Attorney General Keith Ellison announced finalized settlements with four companies, bringing the state's total opioid settlement money to more than $560 million. Ellison joined MPR News Senior Producer Emily Bright to talk about settlement money coming to Minnesota and other top stories moving through his office.

Try these 4 simple and natural hacks to combat pain & inflammation fast. This episode was extracted from Dr. Livingood's YouTube channel. Click here to subscribe: ⁠https://bit.ly/3xUx8kl⁠ Or, click here to view the original video and any links referenced in this podcast: https://www.youtube.com/watch?v=U57XXigLzOE Dr. Livingood recommended supplements & products: Pulse Oximeter and Heart Rate Tool: ⁠https://www.amazon.com/shop/dr.living...⁠ Digestive Enzymes: ⁠https://store.drlivingood.com/product...⁠ Methylated B Vitamins and Multi: ⁠https://store.drlivingood.com/product...⁠ Recommended videos to watch: Inflammation Playlist: ⁠   • Reducing Inflamma...  ⁠ Gut Health Playlist: ⁠   / watchv=lawmmsaew8...  ⁠ Eliminate Inflammation & Magnesium Deficiency: ⁠   • 2 Tbsp a Day to E...  ⁠ Vegetarian Recipes here: ⁠https://drlivingood.com/category/reci...

Our guest on this episode is Mark Cuban. In addition to a storied business career that includes owning the NBA's Dallas Mavericks and a role on ABC's Shark Tank, Mark is the founder and lead investor in the Mark Cuban Cost Plus Drug Company, a generic pharmaceutical distributor that prices medications at cost, plus a 15% administrative markup and any relevant pharmacy and shipping fees. Founded in early 2022, over 1.7M patients have signed up for the service in their first year, and Cost Plus Drugs now offers over 1,000 generic medications for purchase on their website. Mark founded the company with CEO Dr. Alex Oshmyansky, a pediatric radiologist who originally tried to start an organization similar to Cost Plus Drugs as a non-profit, before pivoting and convincing Mark to be his partner. In this episode, I spoke with Mark about: His journey to starting Cost Plus Drugs How the company is able to drive down prices so drastically compared to the existing players How incumbents, such as traditional pharmacy benefit managers and new entrants, such as the Amazon RxPass, will impact the success of Cost Plus Drugs

Hi. Allison Raskin (@AllisonRaskin) joins Cody Johnston to talk about the COVID-19 "Lab Leak Theory," Samuel Alito's sudden concern about fairness in government policy, and Eli Lilly lowering the cost of insulin possibly because of Elon Musk's screw-up. Please fill out our SURVEY: https://kastmedia.com/survey/  Support us on our PATREON: http://patreon.com/somemorenews  Check out our MERCH STORE: https://www.teepublic.com/stores/somemorenews?ref_id=9949  SUBSCRIBE to SOME MORE NEWS: https://tinyurl.com/ybfx89rh   Subscribe to the Even More News and SMN audio podcasts here: Apple Podcasts: https://podcasts.apple.com/us/podcast/some-more-news/id1364825229  Spotify: https://open.spotify.com/show/6ebqegozpFt9hY2WJ7TDiA?si=5keGjCe5SxejFN1XkQlZ3w&dl_branch=1  Stitcher: https://www.stitcher.com/show/even-more-news   Follow us on social media: Twitter: https://twitter.com/SomeMoreNews  Instagram: https://www.instagram.com/SomeMoreNews/  Facebook: https://www.facebook.com/SomeMoreNews/  TikTok: https://www.tiktok.com/@somemorenews  Make CBD a part of reaching your full potential with NextEvo Naturals. Go to https://NextEvo.com/podcast and use promo code MORENEWS to get 20% off your first order of $40 or more. Get a 4-week trial, free postage, and a digital scale at https://www.stamps.com/morenews. Thanks to Stamps.com for sponsoring the show! Stop throwing your money away. Cancel unwanted subscriptions - and manage your expenses the easy way - by going to https://RocketMoney.com/MORENEWS.

Hi. Allison Raskin (@AllisonRaskin) joins Cody Johnston to talk about the COVID-19 "Lab Leak Theory," Samuel Alito's sudden concern about fairness in government policy, and Eli Lilly lowering the cost of insulin possibly because of Elon Musk's screw-up. Please fill out our SURVEY: https://kastmedia.com/survey/  Support us on our PATREON: http://patreon.com/somemorenews  Check out our MERCH STORE: https://www.teepublic.com/stores/somemorenews?ref_id=9949  SUBSCRIBE to SOME MORE NEWS: https://tinyurl.com/ybfx89rh    Subscribe to the Even More News and SMN audio podcasts here: Apple Podcasts: https://podcasts.apple.com/us/podcast/some-more-news/id1364825229  Spotify: https://open.spotify.com/show/6ebqegozpFt9hY2WJ7TDiA?si=5keGjCe5SxejFN1XkQlZ3w&dl_branch=1  Stitcher: https://www.stitcher.com/show/even-more-news   Follow us on social media: Twitter: https://twitter.com/SomeMoreNews  Instagram: https://www.instagram.com/SomeMoreNews/  Facebook: https://www.facebook.com/SomeMoreNews/  TikTok: https://www.tiktok.com/@somemorenews  Make CBD a part of reaching your full potential with NextEvo Naturals. Go to https://NextEvo.com/podcast and use promo code MORENEWS to get 20% off your first order of $40 or more. Get a 4-week trial, free postage, and a digital scale at https://www.stamps.com/morenews. Thanks to Stamps.com for sponsoring the show! Stop throwing your money away. Cancel unwanted subscriptions – and manage your expenses the easy way – by going to https://RocketMoney.com/MORENEWS.Support the show!: http://patreon.com.com/somemorenewsSee omnystudio.com/listener for privacy information.

Coach Blu speaks to Ed Bisch and his battle with Purdue Pharma and the Sackler family concerning OxyContin on this week's podcast. Listen as Ed talks about February 2001, when his life was blindsided as he learned his 18-year-old son Eddie was found unresponsive in his bed. Questing some of his son's friends, he learned that OxyContin had been used unbeknownst to it posed. Police on the scene told Ed that local kids were dying from “Oxy” and the situation worsened. The drug, they said, was spreading quickly across the country and already causing chaos locally.  Bisch has sounded alarms about the dangers of opioids now for more than 2 decades. As the founder of Relatives Against Purdue Pharma (RAPP), he attended countless public hearings, trials, and protests and is a claimant in a class-action lawsuit against the pharmaceutical company, the creators of Oxy. Listen as he describes his lifelong battle for Purdue Pharma and the Sackler family to take responsibility for stealing one out of the millions of lives their medication has taken from loved ones. Bisch's activism got him noticed by others fighting against opioid abuse, including Beth Macy, author of “Dopesick: Dealers, Doctors, and the Drug Company that Addicted America.” Macy wrote about Bisch in her latest book, “Raising Lazarus: Hope, Justice, and the Future of America's Overdose Crisis.” Follow Ed Bisch https://www.judgeforyourselves.com/ https://www.facebook.com/RAPPedB?mibextid=LQQJ4d  Please join Addict to Athlete's Patreon support page and help us turn the mess of addiction into the message of sobriety! https://www.patreon.com/addicttoathlete Please visit our website for more information on Team Addict to Athlete and Addiction Recovery Podcasts. https://www.AddictToAthlete.org

You've probably heard about Brett Favre's involvement in a welfare fraud scandal in his home state of Mississippi. The Hall of Fame quarterback is accused of accepting money intended for the poorest citizens of America's poorest state, and using the money to fund a volleyball facility at his alma mater: the University of Southern Mississippi. But Favre's role in that case only became known to investigators when they began looking into something else entirely: a little-known drug company in Florida that was promising to give the entire football world the miracle it needed around concussion science. Mark Fainaru-Wada investigates the real story behind Prevacus and its gunslinging investor. Learn more about your ad choices. Visit megaphone.fm/adchoices

Can I tap that camel? American Cheese is Neither American nor Cheese. Discuss. I Dont Like Injections in My Peeeeeeeeeeeeeen. Hork It Outta Your Dooda. Brian Ibbott has a very strange AH. American Cheese taste like Government. Mansplaining boobs. Dammit Kevin! The second weirdest thing we heard today. Hocus Pocus 2...End Times. How many cowboys named Vic do you know? Butt-Scratchin' Drug Company. Our time of the month with Dan. Science with Tickle Me Bobby and more on this episode of The Morning Stream.

When journalist and author Beth Macy first pitched a book about the opioid crisis in 2014, her publisher and editor rejected the idea. But Beth kept following the story, publishing “Dopesick: Dealers, Doctors and the Drug Company that Addicted America” in 2018. The book has since been adapted into an Emmy Award-winning Hulu miniseries. Beth joined David to talk about her upbringing in Urbana, Ohio, how the loss of manufacturing jobs and opioid use intersect, the stigmatization of addiction, Trump's appeal in former factory towns, her thoughts on the Sackler family of Purdue Pharma, and her new book, “Raising Lazarus: Hope, Justice, and the Future of the Overdose Crisis.”To learn more about how CNN protects listener privacy, visit cnn.com/privacy

Trump is the Just Tip of the Iceberg -- and What Happens If Biden's DOJ Indicts Trump. Kash Patel, Fmr. DOD Chief of Staff Under Trump, Explains the Shocking Political Overreach of the DOJ. Follow the Science? How About Follow the Money? Covid Windfalls for Drug Companies on Our Dime. Kamala Harris Sounds Like Us After Multiple All-Nighters.Follow Clay & Buck on YouTube: https://www.youtube.com/c/clayandbuckSee omnystudio.com/listener for privacy information.

Serial entrepreneur Mark Cuban was one of the very first guests on How I Built This, way back in 2016. Mark has been founding and investing in startups for decades, but he's never put his name on a company until now. This week on How I Built This Lab, Mark joins Guy to talk about what he's been up to since he was last on the show. They discuss his interest in NFTs and how his latest business, the Mark Cuban Cost Plus Drug Company, is looking to disrupt the pharmaceutical industry. Listen to Mark's original How I Built This episode: https://wondery.com/shows/how-i-built-this/episode/10386-serial-entrepreneur-mark-cuban/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.